German drug discovery and development services company Evotec has appointed Joanna Holbrook as chief scientific officer (CSO) ...
The US Food and Drug Administration (FDA) approved Anktiva (nogapendekin alfa inbakicept-pmln) from Altor BioSciences, an ...
The UK National Institute of Health and Care Excellence (NICE) has issued negative final guidance for the use of Roche’s ...
For someone receiving Casgevy (exagamglogene autotemcel), gene editing involves much more than an infusion. Blood stem cells ...
Japan’s largest drugmaker Takeda today announced that Orzeyful (oveporexton) is now available in Japan and China for the ...
French clinical-stage vaccine company Osivax said its Phase IIb field efficacy trial of OVX836, a nucleoprotein-based ...
US biotech company Verastem Oncology (Nasdaq: VSTM) has priced a $250 million offering alongside new results for its ...
Life science investor Syncona announces that it has committed $10.1 million (£7.5 million) to a $310 million (£230 million) ...
Vir Biotechnology shares jumped nearly 10% in pre-market trading following a major licensing agreement with Gilead Sciences ...
The US regulator, the Food and Drug Administration (FDA), has launched an initiative to reshape rare disease drug development ...
French pharma major Sanofi (Euronext: SAN) must correct potentially misleading messages about a rival flu vaccine and ...
US generative biology company Generate Biomedicines has signed a multi-target collaboration and license agreement with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results